Vilin Bio Med Limited — Important, 31-05-2025: General Updates

Vilin Bio Med has announced a board meeting to consider the financial results for the quarter and half-year. Its license suspension for Tablets and Capsules of Non-beta Lactam products has been revoked, enabling production to resume in these segments. However, operations for Oral Liquid Dosage, External Preparations, Dry Syrups, and Beta Lactam products remain on hold. Partial resumption may aid revenue recovery in key areas, though challenges persist in other product lines.